- Home
- ENX vs SCPH Comparison
ENX vs SCPH Comparison
Compare ENX & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- SCPH
- Stock Information
- Founded
- ENX 2002
- SCPH 2013
- Country
- ENX United States
- SCPH United States
- Employees
- ENX N/A
- SCPH N/A
- Industry
- ENX Finance/Investors Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- ENX Finance
- SCPH Health Care
- Exchange
- ENX Nasdaq
- SCPH Nasdaq
- Market Cap
- ENX 173.1M
- SCPH 173.6M
- IPO Year
- ENX N/A
- SCPH 2017
- Fundamental
- Price
- ENX $9.69
- SCPH $3.25
- Analyst Decision
- ENX
- SCPH Strong Buy
- Analyst Count
- ENX 0
- SCPH 2
- Target Price
- ENX N/A
- SCPH $15.00
- AVG Volume (30 Days)
- ENX 25.4K
- SCPH 267.8K
- Earning Date
- ENX 01-01-0001
- SCPH 03-12-2025
- Dividend Yield
- ENX 3.94%
- SCPH N/A
- EPS Growth
- ENX N/A
- SCPH N/A
- EPS
- ENX 0.16
- SCPH N/A
- Revenue
- ENX N/A
- SCPH $30,278,000.00
- Revenue This Year
- ENX N/A
- SCPH $172.27
- Revenue Next Year
- ENX N/A
- SCPH $131.75
- P/E Ratio
- ENX $61.00
- SCPH N/A
- Revenue Growth
- ENX N/A
- SCPH 303.87
- 52 Week Low
- ENX $7.84
- SCPH $3.08
- 52 Week High
- ENX $10.07
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- ENX 51.97
- SCPH 43.27
- Support Level
- ENX $9.63
- SCPH $3.09
- Resistance Level
- ENX $9.77
- SCPH $3.87
- Average True Range (ATR)
- ENX 0.09
- SCPH 0.20
- MACD
- ENX -0.00
- SCPH 0.00
- Stochastic Oscillator
- ENX 37.04
- SCPH 20.65
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.